417 related items for PubMed ID: 32156603
1. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y, Qian SY, Yuan Y, Wang Q, Gao L, Chen X, Yu X, Zhen Z.
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[Abstract] [Full Text] [Related]
2. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY, Ding Y.
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar 15; 25(3):244-249. PubMed ID: 36946157
[Abstract] [Full Text] [Related]
3. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
Li Y, Zheng Q, Zou L, Wu J, Guo L, Teng L, Zheng R, Jung LKL, Lu M.
Pediatr Rheumatol Online J; 2019 Jan 05; 17(1):1. PubMed ID: 30611297
[Abstract] [Full Text] [Related]
4. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
Clin Chim Acta; 2017 Aug 05; 471():76-80. PubMed ID: 28526535
[Abstract] [Full Text] [Related]
5. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
Indian J Pediatr; 2019 Mar 05; 86(3):250-255. PubMed ID: 30159809
[Abstract] [Full Text] [Related]
6. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr 05; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
7. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Apr 05; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
8. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R.
J Clin Immunol; 2001 May 05; 21(3):193-9. PubMed ID: 11403226
[Abstract] [Full Text] [Related]
9. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 05; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
10. Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.
Zhang H, Song HB, Wang DX, Deng HY, Sun WL.
Pak J Med Sci; 2022 May 05; 38(5):1165-1169. PubMed ID: 35799766
[Abstract] [Full Text] [Related]
11. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
Arthritis Rheumatol; 2015 Jul 05; 67(7):1943-50. PubMed ID: 25778686
[Abstract] [Full Text] [Related]
12. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
Han CL, Zhao SL.
Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902
[Abstract] [Full Text] [Related]
13. Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease.
Nakashima Y, Nanishi E, Yamamura K, Uike K, Terashi E, Hirata Y, Nagata H, Morihana E, Tanaka T, Honjo S, Takada H, Ohga S.
Cytokine; 2019 Feb 11; 114():26-31. PubMed ID: 30583086
[Abstract] [Full Text] [Related]
14. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 11; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
15. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X, Ya-Wang Shao, Ya-Lan Zhang, Yi Liu.
Heart Surg Forum; 2021 Jul 26; 24(4):E611-E618. PubMed ID: 34473042
[Abstract] [Full Text] [Related]
16. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
Lin MT, Chang CH, Sun LC, Liu HM, Chang HW, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH.
J Formos Med Assoc; 2016 May 26; 115(5):350-5. PubMed ID: 25910931
[Abstract] [Full Text] [Related]
17. Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A.
Pediatr Int; 2016 Mar 26; 58(3):180-184. PubMed ID: 26222760
[Abstract] [Full Text] [Related]
18. The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model.
Zhou Y, Wu Y, Yuan C, Yin W, Wang B, Ding Y.
BMC Pediatr; 2023 Dec 19; 23(1):642. PubMed ID: 38114939
[Abstract] [Full Text] [Related]
19. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun 19; 8(3):208-10. PubMed ID: 16787593
[Abstract] [Full Text] [Related]
20. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
Xie L, Zhou C, Wang R, Xiao T, Shen J, Huang M.
Zhonghua Er Ke Za Zhi; 2015 Jan 19; 53(1):34-9. PubMed ID: 25748402
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
